Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
X4 Pharmaceuticals, Inc. (XFOR) is a company in the Health care sector; its shares trade on Nasdaq.
The price of X4 Pharmaceuticals, Inc. (XFOR) on November 12, 2026 is 3.13 $, −3.10 % on the day. Over 52 weeks the stock traded between 2.43 $ and 4.83 $; the price now sits 29 % of the way up that range. Over the past year the price changed by −8.50 %. Market capitalization is 135.74 million $, rank 80 among 134 stocks of the same industry with a known capitalization.
X4 Pharmaceuticals, Inc. trades on Nasdaq under the ticker XFOR. The company belongs to the Health care sector. The trading history on this page starts on 16 November 2017.
Over the past 52 weeks XFOR has traded between 2.43 $ and 4.83 $. As of 12 November 2026 the price stood 33.33% of the way from the 52-week low to the high.
Over one year XFOR shares fell 8.50%; over six months they fell 23.64%. Volatility over 90 days is 64.94%. Dividends are not included: this is price change only, as of 12 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 8.6, above the sector median of 3.9. Price to book is 0.9, below the sector median of 2.4. Calculated from reports for the period ending 30 June 2026.
X4 Pharmaceuticals, Inc. reported revenue of 16M $ and a net loss of 90M $ over the last four quarters. Net margin is −568.80%. Revenue changed by −51.65% year over year. Earnings per share are $1.43. Market capitalisation is 136M $.
XFOR has a return on equity of −57.98%, below the sector median of −40.58%. Return on assets is −35.62%, below the sector median of −30.08%. Operating margin is −554.71%, below the sector median of −20.96%.